Abdullah A, Machkour F, Bouchet E, Plainard X, Descazeaud A
Service de chirurgie urologique et andrologique, CHU de Limoges, 2, avenue de Martin Luther-King, 87100 Limoges, France; Department of surgery (Urology unit), Al-Amiri hospital, Kuwait City, Kuwait.
Service de chirurgie urologique et andrologique, CHU de Limoges, 2, avenue de Martin Luther-King, 87100 Limoges, France.
Prog Urol. 2019 Sep;29(10):490-495. doi: 10.1016/j.purol.2019.07.004. Epub 2019 Aug 3.
To assess the efficacy and the impact on the quality of life (QoL) of patients suffering stress urinary incontinence (SUI) treated with VIRTUE © sling.
Retrospective monocenteric study where patients treated with VIRTUE © sling were included between January 2016 and May 2018. The severity of the incontinence was judged based on the number of protection used per day (PPD) and/or on the 24hours pad test into mild, moderate and severe: ≥2 protections and/or <100ml/24h, 3-4 protections and/or 101-200ml/24h, >4 protections and/or>200ml/24h respectively. The criteria of success was achieved when the patient is dry or ameliorated. The ICIQ- UI sf questionnaire was used as a measure of QoL.
Thirty-five patients were included in this study with mean follow up time of 11 months (range: 3-26). Twenty-nine patients had a radical prostatectomy, 3 had endoscopic treatment for benign prostatic hyperplasia, 9 patient had radiotherapy of which one had a complementary focal treatment (HIFU), and two patients had spinal cord injury. The success rate was 83%. The score ICIQ-UI sf showed a statistical difference between the pre and post-operative periods in both success and failure groups (P<0.001). History of radiotherapy, low bladder compliance, and severe incontinence were associated with negative result. Pain was the most recorded post-operative complication and no>grade 2 Clavien Dindo complications were encountered.
The VIRTUE © sling seems to be an effective, safe tool treating SUI at short term.
评估使用VIRTUE©吊带治疗压力性尿失禁（SUI）患者的疗效及其对生活质量（QoL）的影响。
回顾性单中心研究，纳入2016年1月至2018年5月期间接受VIRTUE©吊带治疗的患者。根据每天使用的防护用品数量（PPD）和/或24小时护垫试验将尿失禁的严重程度分为轻度、中度和重度：分别为≥2次防护用品和/或<100ml/24小时、3 - 4次防护用品和/或101 - 200ml/24小时、>4次防护用品和/或>200ml/24小时。当患者达到干爽或症状改善时即判定为成功。使用ICIQ - UI sf问卷作为生活质量的衡量指标。
本研究共纳入35例患者，平均随访时间为11个月（范围：3 - 26个月）。29例患者接受了根治性前列腺切除术，3例接受了良性前列腺增生的内镜治疗，9例接受了放射治疗，其中1例接受了辅助性局部治疗（高强度聚焦超声），2例患者有脊髓损伤。成功率为83%。ICIQ - UI sf评分在成功组和失败组的术前和术后阶段均显示出统计学差异（P<0.001）。放射治疗史、膀胱顺应性差和严重尿失禁与不良结果相关。疼痛是记录最多的术后并发症，未出现>2级Clavien Dindo并发症。
VIRTUE©吊带似乎是一种短期内治疗SUI有效且安全的工具。
3级。
